Volume 5 Number 2
Editorial
EAPCI column
Focus article
29
Tissue characterisation using intravascular radiofrequency
data analysis: recommendations for acquisition, analysis,
interpretation and reportingGarcía-García H-M, Mintz G, Lerman A, Vince G, Margolis P, van ES G, Morel M, Nair A, Virmani R, Burke A, Stone G, Serruys PW
EuroIntervention 2009;5:177-189
Clinical research
31
Long-term outcome after the V stenting technique in de novo bifurcation lesions using drug-eluting stentsEuroIntervention 2009;5:197-205
32
Ovalum CiTop™ Expander™: a novel guidewire for
crossing coronary chronic total occlusions – first-in-man
(FIM) experienceEuroIntervention 2009;5:206-211
33
Intravascular ultrasound measures of coronary
atherosclerosis are associated with the Framingham risk
score: an analysis from a global IVUS registryMarso S, Frutkin A, Mehta S, House J, McCrary J, Klauss V, Lerman A, Leon M, Nair A, Margolis P, Erbel R, Nasu K, Schiele F, Margolis J
EuroIntervention 2009;5:212-218
34
Impact of stent length on restenosis in patients with acute
myocardial infarction treated with primary percutaneous
coronary intervention: analysis based on data from the Trial
to Assess the Use of the Cypher Stent in Acute Myocardial
Infarction Treated with Balloon Angioplasty (TYPHOON)Rozenman1 Y, Witzling V, Tamari I, Turkisher V, Kriviski M, Bode C, Henry P, Teiger E, Cebrian A, Stoll H, Spaulding C
EuroIntervention 2009;5:219-223
35
Reproducibility of quantitative optical coherence
tomography for stent analysisEuroIntervention 2009;5:224-232
36
The ProLimus trial: a prospective, non-randomised,
multicentre trial to evaluate the safety and clinical
performance of the pimecrolimus eluting stent system
(ProGenic)Verheye S, Sarno G, Muller R, Birkemeyer R, Vrints C, Jung W, Agostoni P, van Langenhove G, Haine S, Willems T, Haude M, Grube E, Wijns W
EuroIntervention 2009;5:224-232
37
Prognostic heterogeneity among patients with chronic
stable coronary disease: determinants of long-term
mortality after treatment with percutaneous interventionLemos P, Campos C, Falcão J, Ribeiro E, Perin M, Kajita L, Filho E, da Gama M, Horta P, Marchiori G, Spadaro A, Martinez E
EuroIntervention 2009;5:239-243
38
Rapid pacing rotational angiography with three-dimensional
reconstruction: use and benefits in structural heart disease
interventions EuroIntervention 2009;5:244-249
39
Long-term results of immunosuppressive oral prednisone
after coronary angioplasty in non-diabetic patients with
elevated C-reactive protein levelsFerrero V, Tomai F, Versaci F, Feola M, Proietti I, Rognoni A, Ghini A, Gaspardone A, Vacca G, De Luca L, Vassanelli C, Ribichini F
EuroIntervention 2009;5:250-254
40
Percutaneous coronary intervention with oral sirolimus and
bare metal stents has comparable safety and efficacy to
treatment with drug eluting stents, but with significant cost
saving: long-term follow-up results from the randomised,
controlled ORAR III (Oral Rapamycin in ARgentina) study
Alfredo E.Rodriguez A, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Granillo R, Rodríguez-Granillo G, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios I, Serruys PW
EuroIntervention 2009;5:255-264
41
Use of the Heartrail II catheter as a distal stent delivery
device; an extended case seriesEuroIntervention 2009;5:265-271
Expert review
Volume 5 Number 2 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Cordis, a Johnson & Johnson company
- Hexacath
- Medtronic
- Terumo



